Invitrogen™ Human TSC2 Synthetic Peptide

Description

• TSC2 Synthetic Peptide, PEP-0251, from Invitrogen
• TSC2 (Tuberin, Tuberous sclerosis complex, TSC Complex Subunit 2), is implicated as a tumor suppressor and may function in vesicular transport, play a role in the regulation of cell growth arrest and in the regulation of transcription mediated by steroid receptors
• TSC2 associates with hamartin in a cytosolic complex, possibly acting as a chaperone for hamartin
• Phosphorylation of tuberin on Ser 939 and Thr 1462 regulates its interaction with hamartin, and is stimulated by various growth factors through the phosphoinositide 3-kinase/Akt pathway
• TSC2 may have a function in vesicular transport, but may also play a role in the regulation of cell growth arrest and in the regulation of transcription mediated by steroid receptors
• Interaction between TSC1 and TSC2 may facilitate vesicular docking
• TSC2 specifically stimulates the intrinsic GTPase activity of the Ras related protein RAP1A and RAB5, suggesting a possible mechanism for its role in regulating cellular growth
• Mutations in TSC2 lead to constitutive activation of RAP1A in tumors and are involved in diseases such as lymphangioleiomyomatosis and TSC2 angiomyolipoma
• Alternative splicing results in transcript variants of three different isoforms of TSC2
• This peptide corresponds to 14 amino acids near the amino terminus of human TSC2.PEP-0251 can be used as a blocking peptide with polyclonal antibody PA5-20133.